Results 311 to 320 of about 5,108,464 (344)
Some of the next articles are maybe not open access.

Gemcitabine in Ovarian Cancer

Seminars in Oncology, 2001
Newer agents and combinations are needed in order to improve current results in the treatment of ovarian cancer. Gemcitabine (Gemzar; Eli Lilly and Company, Indianapolis, IN) is a novel agent with a unique mechanism of action that has shown consistent activity as a single-agent in platinum-resistant ovarian cancer, with remission rates of nearly 20 ...
Mariano Mandachain, Mauro Orlando
openaire   +2 more sources

Ovarian cancer

Seminars in Oncology Nursing, 2002
To review the progress in the management of ovarian cancer in the last decade and future directions.Research studies, review articles, and abstracts.There is an increased understanding of ovarian cancer biology, the genetic basis for hereditary ovarian cancer, staging and the role of cytoreductive surgery, and more effective chemotherapy, resulting in ...
openaire   +2 more sources

Ovarian cancer in pregnancy

Best Practice & Research Clinical Obstetrics & Gynaecology, 2017
Although the occurrence of ovarian masses in pregnancy is relatively common, the majority of them is functional and resolve spontaneously; nevertheless, ovarian cancer is the fifth most common malignancy diagnosed in pregnancy. If malignancy is suspected, treatment should be decided on the basis of gestational age, stage of the disease and patient ...
Robert Fruscio   +7 more
openaire   +5 more sources

Ovarian cancer

Nursing
Abstract: Ovarian cancer, a leading cause of cancer deaths, poses challenges due to insidious development and vague signs and symptoms. Risk factors include age, reproductive history, genetic mutations, and environmental factors. Treatment involves surgery, chemotherapy, and targeted therapy, with nursing interventions focusing on symptom ...
openaire   +2 more sources

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
Hyuna Sung   +2 more
exaly  

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Science, 1989
D. Slamon   +10 more
semanticscholar   +1 more source

Cancer Statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Rebecca L Siegel, Kimberly D Miller
exaly  

Global epidemiology of epithelial ovarian cancer.

Nature Reviews Clinical Oncology
Penelope M. Webb, S. Jordan
semanticscholar   +1 more source

Cancer statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Rebecca L Siegel   +2 more
exaly  

Cancer statistics, 2023

Ca-A Cancer Journal for Clinicians, 2023
Rebecca L Siegel   +2 more
exaly  

Home - About - Disclaimer - Privacy